Loss of structural protein ACTL7B blocks spermatogenesis in male mice

Mature spermatozoa are characterized by an head, midpiece and a long tail for locomotion. Now, researchers from the University Hospital Bonn (UKB) and the Transdisciplinary Research Unit “Life & Health” at the University of Bonn have found that a loss of the structural protein ACTL7B blocks spermatogenesis in male mice.

Biostax and Immgenuity to expedite HIV immunotherapies

IMTVO14 immunotherapy comprises a genetically modified HIV virus. Credit: Corona Borealis Studio/Shutterstock.com. Biostax and Immgenuity have entered a research collaboration agreement to expedite the development

August 30, 2023

Testing the effectiveness of youth activism as a mental health intervention

Three hundred Black and Latinx teens in Chicago will be recruited to participate in the first clinical trial to measure the potential health benefits of

July 13, 2024

Corrected: Roche is not moving forward with SQZ program, sending the biotech into strategic review

This story was corrected to note that Roche has elected not to take its option on SQZ’s program. A previous version said that Roche and

July 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.